CIC
RMD icon

Carnegie Investment Counsel’s ResMed RMD Stock Holding History

Carnegie Investment Counsel’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$940K Hold
4,824
– – 0.02% 325
2026
Q1 		$1.08M Buy
4,824
+13
+0.3% +$3.24K 0.02% 314
2025
Q4 		$1.16M Hold
4,811
– – 0.02% 312
2025
Q3 		$1.32M Sell
4,811
-30
-0.6% -$8.2K 0.02% 289
2025
Q2 		$1.25M Sell
4,841
-170
-3% -$40.6K 0.03% 285
2025
Q1 		$1.07M Sell
5,011
-119
-2% -$27.8K 0.03% 283
2024
Q4 		$1.17M Sell
5,130
-75
-1% -$18.1K 0.03% 247
2024
Q3 		$1.27M Sell
5,205
-25
-0.5% -$5.59K 0.04% 248
2024
Q2 		$1M Buy
5,230
+200
+4% +$40.6K 0.03% 270
2024
Q1 		$996K Sell
5,030
-300
-6% -$55K 0.03% 288
2023
Q4 		$917K Hold
5,330
– – 0.03% 286
2023
Q3 		$788K Hold
5,330
– – 0.03% 296
2023
Q2 		$1.16M Hold
5,330
– – 0.04% 264
2023
Q1 		$1.17M Sell
5,330
-50
-0.9% -$10.8K 0.05% 269
2022
Q4 		$1.12M Sell
5,380
-35
-0.6% -$7.69K 0.05% 269
2022
Q3 		$1.18M Hold
5,415
– – 0.06% 246
2022
Q2 		$1.14M Hold
5,415
– – 0.05% 245
2022
Q1 		$1.31M Hold
5,415
– – 0.05% 240
2021
Q4 		$1.41M Sell
5,415
-225
-4% -$58.4K 0.05% 239
2021
Q3 		$1.49M Hold
5,640
– – 0.06% 214
2021
Q2 		$1.39M Sell
5,640
-100
-2% -$21K 0.05% 226
2021
Q1 		$1.11M Hold
5,740
– – 0.05% 239
2020
Q4 		$1.22M Hold
5,740
– – 0.05% 217
2020
Q3 		$982K Sell
5,740
-100
-2% -$18.5K 0.05% 215
2020
Q2 		$1.12M Buy
5,840
+100
+2% +$16.4K 0.06% 203
2020
Q1 		$841K Hold
5,740
– – 0.06% 212
2019
Q4 		$890K Hold
5,740
– – 0.05% 233
2019
Q3 		$776K Buy
5,740
+100
+2% +$13.1K 0.05% 235
2019
Q2 		$688K Sell
5,640
-990
-15% -$110K 0.04% 258
2019
Q1 		$689K Buy
6,630
+100
+2% +$10.3K 0.05% 255
2018
Q4 		$744K Sell
6,530
-8,000
-55% -$857K 0.07% 215
2018
Q3 		$1.51M Buy
14,530
+7,800
+116% +$854K 0.12% 166
2018
Q2 		$728K Hold
6,730
– – 0.06% 231
2018
Q1 		$686K Hold
6,730
– – 0.06% 223
2017
Q4 		$626K Sell
6,730
-50
-0.7% -$4.13K 0.06% 249
2017
Q3 		$541K Hold
6,780
– – 0.06% 242
2017
Q2 		$495K Sell
6,780
-1,295
-16% -$92.7K 0.06% 244
2017
Q1 		$552K Sell
8,075
-475
-6% -$32.8K 0.07% 228
2016
Q4 		$529K Hold
8,550
– – 0.07% 217
2016
Q3 		$549K Sell
8,550
-50
-0.6% -$3.33K 0.08% 211
2016
Q2 		$561K Buy
8,600
+345
+4% +$20.3K 0.08% 210
2016
Q1 		$476K Buy
8,255
+300
+4% +$17K 0.07% 210
2015
Q4 		$452K Hold
7,955
– – 0.08% 207
2015
Q3 		$456K Hold
7,955
– – 0.08% 202
2015
Q2 		$448K Hold
7,955
– – 0.08% 205
2015
Q1 		$589K Buy
7,955
+400
+5% +$26K 0.1% 182
2014
Q4 		$437K Hold
7,555
– – 0.08% 198
2014
Q3 		$372K Sell
7,555
-5,930
-44% -$302K 0.07% 212
2014
Q2 		$683K Sell
13,485
-40
-0.3% -$1.98K 0.16% 132
2014
Q1 		$604K Sell
13,525
-1,200
-8% -$53.9K 0.16% 128
2013
Q4 		$693K Buy
14,725
+2,060
+16% +$104K 0.19% 117
2013
Q3 		$669K Sell
12,665
-550
-4% -$26.7K 0.21% 114
2013
Q2 		$596K Buy
+13,215
New +$627K 0.2% 120

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Carnegie Investment Counsel's RMD Position: Q2 2026 in Review

Carnegie Investment Counsel held its ResMed (RMD) position steady in Q2 2026 at 4,824 shares worth $940K. The position accounts for 0.02% of the portfolio, ranked #325.

Carnegie Investment Counsel first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.51M in Q3 2018. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Carnegie Investment Counsel held 4,824 shares of ResMed worth $940K as of Q2 2026.
  • Carnegie Investment Counsel left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.02% of Carnegie Investment Counsel's portfolio in Q2 2026, its #325 holding.
  • Carnegie Investment Counsel first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • Carnegie Investment Counsel's ResMed position peaked at $1.51M in Q3 2018.
  • 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.